# Prophylactic Antibiotics for Urinary Tract Infections After Robot-Assisted Radical Cystectomy

> **NCT04502095** · PHASE4 · COMPLETED · sponsor: **Roswell Park Cancer Institute** · enrollment: 89 (actual)

## Conditions studied

- Bladder Carcinoma
- Refractory Bladder Carcinoma
- Urinary Tract Infection

## Interventions

- **DRUG:** Clindamycin
- **OTHER:** Diary
- **DRUG:** Ertapenem
- **DRUG:** Levofloxacin
- **DRUG:** Nitrofurantoin
- **DRUG:** Trimethoprim-Sulfamethoxazole

## Key facts

- **NCT ID:** NCT04502095
- **Lead sponsor:** Roswell Park Cancer Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-09-02
- **Primary completion:** 2025-03-13
- **Final completion:** 2025-03-13
- **Target enrollment:** 89 (ACTUAL)
- **Last updated:** 2025-08-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04502095

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04502095, "Prophylactic Antibiotics for Urinary Tract Infections After Robot-Assisted Radical Cystectomy". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT04502095. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
